HCA Stock Recent News
HCA LATEST HEADLINES
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conference: September 4, 2025 at 2:15pm ET at the Wells Fargo 2025 Healthcare Conference. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The healthcare sector has experienced a 0.79% decline year-to-date, making it the worst performer among the S&P 500's 11 sectors and the only one in negative territory. But unlike other market-lagging sectors that have performed better of late (e.g.
HCA Healthcare is the best-managed U.S. hospital chain, offering essential services and resilient financials, making it a strong buy for diversified portfolios. Recent results show robust revenue and EPS growth, with aggressive share repurchases and manageable debt supporting shareholder returns. Valuation is attractive: a 16x multiple on 2025 EPS yields a $416 fair value, implying a 25% total return potential from current levels.
HCA Healthcare's Q2 earnings rose 24% year over year on stronger patient volumes. EPS for 2025 is expected to be within $25.5-$27, up from the earlier view of $24.05-$25.85.